Pearson J. Michael 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Apr 26, 2012
Insider Transaction Report
Form 4
Pearson J. Michael
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock, no par values
2012-04-24−101,877→ 6,488,430 total
Footnotes (2)
- [F1]Represents common shares withheld to satisfy certain tax obligations at the time of release.
- [F2]This number represents common shares purchased by the Reporting Person, common shares received upon settlement and/or exercise of previously granted equity awards, as well as other outstanding equity awards that were previously reported in Table 1.